Barbados vs Oman: Estimated antiretroviral therapy coverage among people living with HIV
Barbados
67.0%
in 2025
Oman
68.0%
in 2025
Barbados rank
92nd
Oman rank
90th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Barbados
- Oman
How they compare
Oman currently reports 68.0% against 67.0% in Barbados, a difference of 1.0%.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Oman ahead.
Barbados ranks 92nd and Oman ranks 90th of 143 countries.
Barbados has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Barbados | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.4% | 18.0% | 2.4% | Barbados |
| 2010s | 52.7% | 37.8% | 14.9% | Barbados |
| 2020s | 64.8% | 61.5% | 3.3% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Barbados or Oman?
- Oman, at 68.0% against 67.0% in Barbados as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Barbados and Oman?
- 1.0%, with Oman ahead.
- How many years of comparable data are there for Barbados and Oman?
- 26 years are reported by both, from 2000 to 2025.
- How do Barbados and Oman rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Barbados ranks 92nd and Oman ranks 90th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.